Hearing Care Program for Mild Cognitive Impairment

(K-HEARS MCI Trial)

Recruiting in Palo Alto (17 mi)

Overseen by Hae-Ra Han, PhD, RN

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Johns Hopkins University

Trial Summary

What is the purpose of this trial?

The objective of this study is to develop and assess the feasibility, acceptability, and preliminary efficacy of a community-delivered, affordable, and accessible hearing care intervention tailored to the needs of community-dwelling Korean American (KA) older adults with mild cognitive impairment (MCI) and their care partners that integrates a low-cost over-the-counter amplification device and hearing rehabilitation through a randomized controlled pilot study. Each dyad will consist of the study participant and their care partner.

Eligibility Criteria

This trial is for Korean American adults over 60 with mild cognitive impairment and hearing loss, who can read and speak Korean. They must not be using a hearing aid but have a care partner willing to join the study. Participants should also be on stable medication regimens.

Inclusion Criteria

You identify as a first-generation Korean American.

You have a hearing loss of at least 25 decibels in the better ear tested across 1, 2 and 4 kHz frequencies.

My medication doses for mental health have been stable for at least 2 weeks.

Participant Groups

The K-HEARS intervention being tested includes an affordable sound amplifier device and hearing rehabilitation tailored for first-generation Korean American older adults with MCI. The study will assess its feasibility, acceptability, and preliminary effectiveness through a randomized pilot study.

Group I: Phase 2B -KA Older Adult Focused Trial (non-randomized) Experimental Treatment 2 Interventions

Immediate treatment with K-HEARS intervention

Group II: Phase 2A -MCI Pilot Trial Immediate Treatment Group Experimental Treatment 2 Interventions

Immediate treatment with K-HEARS intervention

Group III: Phase 2A -MCI Pilot Trial Delayed Treatment Group Placebo Group 2 Interventions

6-month delayed treatment with K-HEARS intervention

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Johns Hopkins School of Nursing Baltimore, MD

Who Is Running the Clinical Trial?

Johns Hopkins University Lead Sponsor

National Institute on Deafness and Other Communication Disorders (NIDCD) Collaborator

References